EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Modeling Partial and Total Support of Left Ventricular Assist Device for Discrete Hemodynamic Control Framework

Yasuyuki Kataoka, Kazunori Uemura, Mitsuji Sampei, Yukiko Fukuda, Jon Peterson, Takuya Nishikawa, Keita Saku, Joe Alexander, Kenji Sunagawa

IEEE Transactions on Biomedical Engineering · 2026-08 · 73 (8) · 2695-2708

DOI: 10.1109/tbme.2026.3706753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IEEE Transactions on Biomedical Engineering, 2026-08. Verfasst von Yasuyuki Kataoka und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Heart-Assist Devices, Models, Cardiovascular, Hemodynamics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NTT Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study develops a model-based control framework integrating a left ventricular assist device (LVAD) with drug therapy to regulate multidimensional hemodynamics (mean arterial pressure, cardiac output, and left and right atrial pressures) while minimizing myocardial oxygen consumption ($MVO_{2}$) in acute heart afailure (AHF). By modeling the hemodynamic and $MVO_{2}$ effects of partial and total LVAD support, the framework enables combined drugs-LVAD therapy for severe AHF cases where drug therapy alone is not effective. METHODS: A previously developed hemodynamic control framework was extended to incorporate LVAD support. Using circulatory equilibrium models under LVAD support, an analytical $MVO_{2}$ model encompassing both LVAD modes was derived from the relationship between $MVO_{2}$ and the ventricular pressure-volume area. An optimal controller explicitly accounts for transitions between partial and total LVAD support. In our cardiovascular simulator, we validated the $MVO_{2}$ model and evaluated the framework's multidimensional hemodynamic regulation and $MVO_{2}$ minimization capabilities. RESULTS: The $MVO_{2}$ model accurately predicted $MVO_{2}$ across the two LVAD modes. In a severe AHF scenario, drug therapy or LVAD support alone failed, whereas the combined drugs-LVAD controller succeeded in achieving both hemodynamic regulation and $MVO_{2}$ minimization. Compared with drug therapy alone, drugs-LVAD control using the proposed $MVO_{2}$ model halved $MVO_{2}$ while achieving multidimensional regulation. CONCLUSIONS: Our drugs-LVAD framework may enable multidimensional hemodynamic regulation while reducing $MVO_{2}$ in severe AHF. Modeling both partial and total LVAD support may be essential for hemodynamic management. SIGNIFICANCE: This work provides a theoretical basis for integrated drugs-LVAD control to achieve target hemodynamics while reducing cardiac workload.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesModels, CardiovascularHemodynamicsHumansComputer SimulationHeart FailureOxygen Consumption

Förderung

  • NTT Research

Zitieren

APA

Kataoka, Y., Uemura, K., Sampei, M., Fukuda, Y., Peterson, J., Nishikawa, T., Saku, K., Alexander, J., & Sunagawa, K. (2026). Modeling Partial and Total Support of Left Ventricular Assist Device for Discrete Hemodynamic Control Framework. IEEE Transactions on Biomedical Engineering, 73(8), 2695-2708. https://doi.org/10.1109/tbme.2026.3706753

Vancouver

Kataoka Y, Uemura K, Sampei M, Fukuda Y, Peterson J, Nishikawa T, et al. Modeling Partial and Total Support of Left Ventricular Assist Device for Discrete Hemodynamic Control Framework. IEEE Transactions on Biomedical Engineering. 2026;73(8):2695-2708. doi:10.1109/tbme.2026.3706753

BibTeX
@article{Kataoka2026,
  author = {Kataoka, Yasuyuki and Uemura, Kazunori and Sampei, Mitsuji and Fukuda, Yukiko and Peterson, Jon and Nishikawa, Takuya and Saku, Keita and Alexander, Joe and Sunagawa, Kenji},
  title = {Modeling Partial and Total Support of Left Ventricular Assist Device for Discrete Hemodynamic Control Framework},
  journal = {IEEE Transactions on Biomedical Engineering},
  year = {2026},
  volume = {73},
  number = {8},
  pages = {2695--2708},
  doi = {10.1109/tbme.2026.3706753}
}
Kostenlos starten →